» Authors » Glenn Francis

Glenn Francis

Explore the profile of Glenn Francis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 2305
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
OSullivan S, Shilova M, Webb A, Francis G, Robertson J, Gupta R, et al.
Am J Med Genet A . 2025 Jan; e63976. PMID: 39789873
We describe the phenotypic and genotypic spectrum of patients with vascular anomaly (VA) in a paediatric multi-disciplinary VA clinic. We measured the clinical utility of genotyping by comparing pre and...
2.
Theile H, Sommerville S, Yang S, Francis G, Williamson R
ANZ J Surg . 2020 Mar; 90(11):2378-2380. PMID: 32141640
No abstract available.
3.
Agaram N, Zhang L, Sung Y, Cavalcanti M, Torrence D, Wexler L, et al.
Am J Surg Pathol . 2019 Feb; 43(5):695-702. PMID: 30720533
Primary intraosseous rhabdomyosarcomas (RMSs) are extremely rare. Recently 2 studies reported 4 cases of primary intraosseous RMS with EWSR1/FUS-TFCP2 gene fusions, associated with somewhat conflicting histologic features, ranging from spindle...
4.
Haffajee Z, Kumar B, Francis G, Peck M, Badrick T
Appl Immunohistochem Mol Morphol . 2017 Dec; 27(5):339-344. PMID: 29189257
The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP) Anatomical Pathology provides a comprehensive External Quality Assurance (EQA) exercise to review the reporting of immunohistochemistry (IHC) and in-situ...
5.
Kumarasinghe M, Morey A, Bilous M, Farshid G, Francis G, Lampe G, et al.
Pathology . 2017 Aug; 49(6):575-581. PMID: 28823752
This Australian human epidermal growth factor receptor 2 (HER2) testing program aimed to analyse >800 cases tested in a coordinated setting to further evaluate the criteria to establish HER2 status...
6.
Quan J, Zhou C, Johnson N, Francis G, Dahlstrom J, Gao J
Pathology . 2017 Feb; 44(4):388. PMID: 28193350
No abstract available.
7.
Francis G, Stein S
Int J Mol Sci . 2015 Jun; 16(6):14122-42. PMID: 26101870
With the development of new sensitive molecular techniques, circulating cell-free tumour DNA containing mutations can be identified in the plasma of cancer patients. The applications of this technology may result...
8.
Torlakovic E, Nielsen S, Francis G, Garratt J, Gilks B, Goldsmith J, et al.
Appl Immunohistochem Mol Morphol . 2014 Dec; 23(1):1-18. PMID: 25474126
Diagnostic immunohistochemistry (dIHC) has been practiced for several decades, with an ongoing expansion of applications for diagnostic use, and more recently for detection of prognostic and predictive biomarkers. However, standardization...
9.
Torlakovic E, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, et al.
Appl Immunohistochem Mol Morphol . 2014 Apr; 22(4):241-52. PMID: 24714041
Standardization of controls, both positive and negative controls, is needed for diagnostic immunohistochemistry (dIHC). The use of IHC-negative controls, irrespective of type, although well established, is not standardized. As such,...
10.
Quan J, Zhou C, Johnson N, Francis G, Dahlstrom J, Gao J
Pathology . 2012 Mar; 44(3):221-7. PMID: 22406484
Aims: This study investigates whether matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, interacting with other molecules important in osteoblast differentiation and osteoclastogenesis, could play important roles in the invasion of...